Sommerer, C., Legendre, C., Citterio, F., Watarai, Y., Oberbauer, R., Basic-Jukic, N., . . . Chadban, S. (2023). Cardiovascular outcomes in de novo Kidney transplant recipients receiving everolimus and reduced calcineurin inhibitor or standard triple therapy: 24-month post hoc analysis from TRANSFORM study. Transplantation, 107(7), . https://doi.org/10.1097/TP.0000000000004555
Chicago-Zitierstil (17. Ausg.)Sommerer, Claudia, et al. "Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis from TRANSFORM Study." Transplantation 107, no. 7 (2023). https://doi.org/10.1097/TP.0000000000004555.
MLA-Zitierstil (9. Ausg.)Sommerer, Claudia, et al. "Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis from TRANSFORM Study." Transplantation, vol. 107, no. 7, 2023, https://doi.org/10.1097/TP.0000000000004555.